Bachem is a Swiss CDMO founded in 1971 that manufactures peptide and oligonucleotide APIs for pharmaceutical and biotech companies worldwide. The company operates four GMP-certified manufacturing sites globally and supplies approximately two-thirds of all globally approved peptide APIs today.
Bachem’s catalog covers thousands of peptides priced from $83 to $785 (USD) per vial. Custom synthesis runs from 5 mg to multi-ton scale. The generic API portfolio includes Glucagon, Leuprolide Acetate, Octreotide Acetate, and Goserelin Acetate. Regulatory credentials include 18 Drug Master Files, 9 CEPs, and FDA and Swissmedic certifications.
This review covers Bachem’s synthesis methods, full product range, competitor comparisons against GenScript and MilliporeSigma, regulatory certifications, and pricing details. It also explains which buyers are best served by Bachem and where lower-cost research-grade alternatives make more practical sense.
What Are Bachem Peptides?
Bachem is a Swiss Contract Development and Manufacturing Organisation (CDMO) that has specialized exclusively in peptide and oligonucleotide production since 1971. The company develops and manufactures Active Pharmaceutical Ingredients (APIs) for pharmaceutical and biotechnology clients worldwide. Here’s the thing: no other CDMO matches Bachem’s depth of peptide-exclusive focus across five decades.
Bachem operates four GMP-certified manufacturing sites: Bubendorf and Vionnaz in Switzerland, plus Torrance and Vista in California. Each location serves distinct scales and product types, from early-phase development batches to multi-ton commercial supply runs.
The company currently produces approximately two-thirds of all globally approved peptide APIs. That figure speaks for itself. It reflects both the scale of Bachem’s operations and the trust that major pharmaceutical companies place in its manufacturing expertise.
Bachem’s Core Business Areas:
- Peptide API manufacturing for pharmaceutical and biotech clients
- Custom peptide synthesis from milligram to metric-ton scale
- Catalog peptides for research and reference applications
- Cosmetic peptides for skincare ingredient manufacturers
- Oligonucleotide development and manufacturing
How Long Has Bachem Been Manufacturing Peptides?
Bachem has been manufacturing peptides for over 50 years. The company stands as one of the oldest and most established peptide producers in the world. The company was founded in 1971 by Dr. Peter Grogg in Switzerland, pioneering solid-phase peptide synthesis at commercial scale. Five decades of uninterrupted focus on peptide chemistry is unusual even among specialty chemical manufacturers.
And here’s what that longevity actually means: Bachem has participated in more than 20 FDA drug approvals involving peptide APIs. No single competitor comes close to matching that number. The historical track record gives pharmaceutical clients confidence when selecting a supplier for long-term commercial programs.
Who Does Bachem Serve?
Bachem primarily serves pharmaceutical and biotechnology companies that require GMP-certified peptides for clinical trials or commercial drug manufacturing. The client base ranges from early-stage biotech firms initiating Phase I trials to large multinational pharmaceutical companies producing commercial-scale API tonnage. Academic researchers represent a smaller but active segment.
Individual consumers and general wellness buyers are not Bachem’s target market. Bottom line: the company’s minimum order thresholds and pharma-grade pricing are calibrated for industrial and institutional buyers. Researchers seeking small research quantities often purchase through authorized distributors rather than directly from Bachem.
How Does Bachem Manufacture Peptides?
Bachem manufactures peptides using solid-phase peptide synthesis (SPPS) as its primary method, supported by solution-phase liquid synthesis for specific applications. SPPS involves building a peptide chain on a solid resin support by sequentially adding protected amino acids and removing temporary protecting groups after each coupling step. The process runs on automated synthesizers in high-throughput configurations.
Solution-phase synthesis complements SPPS for cases requiring specific C-terminus modifications or very short peptides. The method takes place entirely in liquid phase, offering greater flexibility for structural modifications. And here’s the scale: Bachem’s 8,000-liter solution-phase reactors represent industrial-grade capacity for the world’s highest-demand peptides.
After synthesis, peptides undergo purification via preparative HPLC to remove impurities and side products. The purification step determines the final purity grade. In fact, Bachem’s pharmaceutical-grade products routinely achieve 98-99% purity or higher — a standard that defines the benchmark for the entire industry.
What Synthesis Methods Does Bachem Use?
Bachem employs Fmoc-based solid-phase peptide synthesis for most products and liquid-phase synthesis for specialized applications requiring C-terminus modifications. In SPPS, temporary Fmoc protecting groups shield the alpha-amine of each amino acid during coupling, while permanent protecting groups guard side chains and the C-terminus throughout the entire chain assembly. Coupling reagents activate carboxyl groups to drive peptide bond formation.
The company also uses Tag-Assisted Peptide Synthesis (TAPS), a proprietary technology developed specifically for cosmetic peptide production. TAPS enables precise control over purity and yield at both small and large batch scales. The technology is especially suited to short cosmetic peptides that require tailored production parameters.
Synthesis Method Comparison:
| Method | Best For | Scale Range | Primary Advantage |
| SPPS (Fmoc) | Most peptide sequences | mg to kg | Automated, reproducible |
| Liquid-Phase | Short peptides, C-term mods | g to multi-ton | High flexibility |
| TAPS | Cosmetic peptides | Small to large batch | Tailored purity control |
How Does Bachem Control Peptide Purity?
Bachem uses HPLC and mass spectrometry (MALDI-MS) as standard quality control release testing for every peptide product it manufactures. Each batch receives a Certificate of Analysis documenting purity, identity, and relevant analytical data. The COA also includes full impurity profiles and endotoxin testing results for GMP-grade products. Five-year archival of batch records supports regulatory inspections at any time.
Here’s the part most people miss: over 20% of Bachem’s total workforce works in quality and regulatory roles. That’s significantly higher than the industry average for specialty chemical manufacturers. Advanced analytical services extend to net peptide content determination, residual solvent analysis, and Karl Fischer moisture titration.
Quality Control Testing Included in COA:
- HPLC purity with full peak data
- Mass spectrometry identity confirmation
- Endotoxin testing via LAL assay
- Residual solvent disclosure including TFA content
- Moisture content via Karl Fischer titration
- Net peptide content determination
What Products Does Bachem Offer?
Bachem offers four main product categories: catalog peptides, custom synthesis services, peptide API drug substances, and cosmetic peptides. The catalog covers thousands of ready-to-order peptides including neuropeptides, peptide inhibitors, peptide substrates, and amino acid derivatives. Custom synthesis accommodates unique sequences not found in the catalog, from milligram research quantities to kilogram commercial batches.
The peptide API segment supplies drug substances for pharmaceutical formulation, including both exclusive NCEs under development and established generic APIs. Current generic API products include Glucagon, Goserelin Acetate, Leuprolide Acetate, Octreotide Acetate, and Triptorelin. These are widely used in oncology, endocrinology, and emergency medicine treatments.
Generic Peptide API Products Available:
- Glucagon (emergency hypoglycemia treatment)
- Goserelin Acetate (hormone therapy for prostate and breast cancer)
- Leuprolide Acetate (prostate cancer and endometriosis)
- Octreotide Acetate (acromegaly and carcinoid syndrome)
- Triptorelin (prostate cancer and central precocious puberty)
Does Bachem Sell Research Peptides?
Yes. Bachem sells research-grade peptides through its online shop at shop.bachem.com, available without minimum order requirements for many catalog items. Research peptides are available in purity grades from 80% to 97% depending on the intended application. Non-GMP custom synthesis starts from 5 mg (milligrams) quantities up to 100 g (grams). The scale range is accessible to academic researchers and small biotech teams.
Purity recommendations vary by application. To be clear: NMR studies or enzyme-substrate research typically require over 95% purity. Antibody production and quantitative assays like ELISA work with 90-95% purity. Western blotting studies are compatible with 80%+ purity grades, reducing per-unit cost for lower-precision applications.
Does Bachem Make Cosmetic Peptides?
Yes. Bachem produces cosmetic peptides for skincare formulations including collagen synthesis enhancers and skin firming actives, using its proprietary Tag-Assisted Peptide Synthesis platform. The cosmetic peptide line targets cosmetics manufacturers rather than direct consumers, supplying active ingredients for anti-aging, skin elasticity, and barrier function products. Batches range from early development quantities to commercial-scale production.
The production process offers green manufacturing options with CMR-free processes on request. And here’s what that means for buyers: a European skincare company cited a 14-year supply relationship with Bachem, crediting consistent product quality and responsive customer service. The longevity of such relationships is unusual in ingredient supply chains.
What Do Bachem Peptide Reviews Say?
Industry reviews consistently rank Bachem as the gold standard for pharmaceutical peptide manufacturing, with perfect five-star ratings across quality, regulatory status, technical capabilities, and service reliability. Independent ranking platforms list Bachem as the top-rated peptide manufacturer in 2025, tied only with CPC Scientific in overall quality assessments. The recurring theme across professional reviews is reliability and regulatory depth.
So what’s the full picture? Employee reviews on Glassdoor average 3.0 out of 5 stars from 151 reviews, indicating an average internal work environment. This gap between external industry acclaim and internal employee satisfaction is worth noting for organizations considering long-term supplier relationships involving embedded teams.
What Are the Positive Reviews of Bachem?
Positive reviews highlight Bachem’s unmatched regulatory documentation, consistent batch-to-batch quality, and the ability to scale from grams in early development to metric tons in commercial manufacturing. Pharmaceutical companies repeatedly credit Bachem with supplying the cleanest COAs in the industry, including full impurity profiles and endotoxin data as standard deliverables rather than optional add-ons. No other manufacturer routinely includes all five critical quality metrics in a single batch report.
In fact, customers also praise the company’s project management structure, which pairs clients with dedicated teams across analytical, regulatory, and manufacturing functions. The integrated team model reduces coordination overhead during IND filing and NDA submission phases. Several customers cite regulatory inspection support as the single biggest differentiator over less experienced CDMOs.
What Are the Common Complaints About Bachem?
The most common complaint about Bachem is pricing, which sits at the premium end of the market and includes high minimum order thresholds that make Bachem inaccessible for individual researchers and small academic labs. Catalog peptides range from $83 (USD) to $785 (USD) per vial, with custom synthesis requiring direct contact for quotes rather than transparent online pricing. Several researchers specifically recommended cheaper alternatives for non-pharmaceutical research purposes.
Is turnaround time a problem? For some buyers, yes. GMP-grade custom synthesis involves extensive documentation and quality review steps, which add lead time compared to research-grade suppliers operating without GMP constraints. Buyers with urgent research needs sometimes find faster fulfillment from non-GMP competitors at significantly lower prices.
How Does Bachem Compare to Competitors?
Bachem leads the global peptide manufacturing market alongside Thermo Fisher Scientific, Merck KGaA, GenScript, and CEM Corporation in a $1.41 billion (USD) industry projected to grow through 2029. Each major player occupies a distinct position: Bachem dominates pharma-grade GMP manufacturing, GenScript targets high-throughput custom research synthesis, and Sigma-Aldrich maintains the largest catalog library in the world. Choosing among them depends on application requirements, regulatory needs, and budget.
For pharmaceutical companies requiring clinical-grade APIs, Bachem and PolyPeptide Group are the two primary options. PolyPeptide Group holds FDA-registered cGMP facilities and specializes in therapeutic development services similar to Bachem. Both charge premium pricing that reflects their regulatory infrastructure.
Peptide Manufacturer Comparison:
| Company | Best For | Typical Purity | GMP Certified | Price Range |
| Bachem | Pharma API supply | 98-99%+ | Yes (4 sites) | $83-$785+ (USD) |
| GenScript | Research and GMP | 95%+ | Partial | Contact for quote |
| MilliporeSigma | Catalog reference | Variable | FDA-registered | Catalog pricing |
| PolyPeptide Group | Therapeutic dev. | 98%+ | Yes | Premium |
| CPC Scientific | Biotech startups | 95%+ | Mid-tier | Mid-range |
Bachem vs GenScript: Which Is Better?
Bachem outperforms GenScript for pharmaceutical-grade GMP manufacturing, while GenScript surpasses Bachem for high-throughput research synthesis at lower price points. GenScript’s PepPower technology achieves 95%+ synthesis success rates using a combination of SPPS, liquid-phase, and microwave synthesis methods. GenScript is publicly traded on the Hong Kong Stock Exchange (HKEX: 1548). This status gives the company transparent financial and operational disclosure requirements. Some GenScript synthesis occurs at Chinese facilities, which introduces country-of-origin considerations for GMP-sensitive programs.
Here’s why that matters for pharma buyers: Bachem has supported over 20 FDA-approved peptide drugs, a record GenScript hasn’t matched at the same scale. For programs heading toward NDA submission, Bachem’s established DMF portfolio and CEP documentation reduces the regulatory burden on the client’s drug development team significantly.
Bachem vs MilliporeSigma: What Is the Difference?
MilliporeSigma offers the world’s largest catalog peptide library with standardized lot-specific COAs accessible online, while Bachem focuses on higher-complexity GMP manufacturing that MilliporeSigma does not replicate at scale. Merck KGaA’s MilliporeSigma division is the default choice for standard catalog reference peptides used in academic research and early-stage screening. Its online lot-specific COA lookup is a practical advantage for quality teams needing documentation quickly.
Think of it this way: MilliporeSigma wins on catalog breadth and research accessibility, while Bachem wins on GMP depth, regulatory support, and commercial API manufacturing. The two companies rarely compete directly for the same client contract because their core capabilities and client profiles do not overlap significantly.
Is Bachem FDA Approved and Legit?
Yes. Bachem maintains active FDA manufacturing licenses for both its Torrance and Vista, California facilities and has passed multiple FDA inspections over the course of its operational history. The company also holds Swissmedic manufacturing licenses for its Swiss sites, plus foreign manufacturer accreditation from Japan’s PMDA for all four global locations. Regulatory approvals from Brazil’s ANVISA and China’s CDE round out Bachem’s international compliance portfolio.
The good news? The company’s regulatory standing is backed by 18 active Drug Master Files (DMFs) and nine Certificates of Suitability (CEPs) recognized across multiple regulatory jurisdictions. DMFs allow pharmaceutical clients to reference Bachem’s manufacturing data during their own drug applications without disclosing proprietary manufacturing details. This infrastructure is expensive to build and maintain, which is why few CDMOs operate at Bachem’s regulatory depth.
What Regulatory Certifications Does Bachem Hold?
Bachem holds GMP compliance certificates for its Swiss operations and ISO 13485 certification for its UK facility, alongside cGMP certifications at all US sites. The ISO 13485 standard specifically covers quality management for medical devices and in-vitro diagnostics, which positions Bachem to supply peptides for diagnostic kit manufacturers in addition to pharmaceutical clients. Manufacturing processes comply with ICH Q7 guidelines for pharmaceutical active ingredients.
Over 20% of Bachem’s total staff work in quality and regulatory functions. That’s significantly higher than the industry average for specialty chemical manufacturers. The five-year batch record archival policy ensures that historical production data remains available for regulatory audits long after product launch.
Bachem Regulatory Certifications Summary:
- FDA manufacturing licenses (Torrance and Vista, California)
- Swissmedic licenses (Bubendorf and Vionnaz, Switzerland)
- PMDA foreign manufacturer accreditation (Japan, all 4 sites)
- 18 active Drug Master Files (global)
- 9 Certificates of Suitability (CEPs)
- ISO 13485 certification (UK facility)
- GMP compliance per ICH Q7 guidelines
How Much Do Bachem Peptides Cost?
Bachem’s catalog peptides range from approximately $83 (USD) to $785 (USD) per vial depending on the specific peptide and pack size, with Peptide YY (3-36) priced at $285.05 (USD) as a representative mid-range example. Volume discounts are available for multi-vial purchases: 2 vials receive a 5% discount, 3-5 vials receive 10% off, and 6-9 vials qualify for 15% reduction. Purchases of 10 or more vials require direct contact with Bachem’s sales team for bulk pricing.
Custom synthesis pricing is not disclosed publicly and requires a direct quotation. Non-GMP custom synthesis starts at 5 mg (milligrams) and scales to 100 g (grams) for research applications. GMP-grade custom synthesis involves additional validation, documentation, and quality review costs that substantially increase per-gram pricing compared to research-grade alternatives.
Bachem Volume Discount Structure:
| Quantity | Discount | How to Order |
| 1 vial | No discount | Online shop |
| 2 vials | 5% off | Online shop |
| 3-5 vials | 10% off | Online shop |
| 6-9 vials | 15% off | Online shop |
| 10+ vials | Bulk pricing | Contact sales |
Is Bachem Worth the Price?
For pharmaceutical companies, Bachem is worth the premium pricing because the regulatory documentation, GMP infrastructure, and 50-year track record reduce downstream drug approval risk in ways that cheaper alternatives cannot match. The cost of a failed drug application or a manufacturing deficiency finding from the FDA far exceeds the pricing differential between Bachem and lower-cost peptide suppliers. For companies advancing peptide drugs through clinical trials, Bachem’s pricing reflects genuine risk mitigation value.
For individual researchers and academic labs, the value equation is less clear. Catalog peptides in the $83-$785 (USD) range carry costs that are not competitive with research-grade alternatives from companies like CPC Scientific or GenScript. Researchers without GMP requirements are better served by non-GMP suppliers offering comparable purity at lower unit costs.
Where Can You Buy Bachem Peptides?
Bachem peptides are available for direct purchase through the company’s online shop at shop.bachem.com, which lists thousands of catalog peptides with available pack sizes and current pricing. The shop accepts orders from qualified research institutions, pharmaceutical companies, and authorized distributors worldwide. Special offers and discounted catalog items are listed separately on the site’s special offers page for buyers managing research budgets.
Bachem products are also distributed through authorized third-party laboratory suppliers including Fisher Scientific, which lists specific Bachem peptides with current US pricing. Purchasing through a distributor can simplify procurement for institutions that maintain preferred supplier agreements with large laboratory supply chains. Custom synthesis and GMP API requests are handled exclusively through Bachem’s direct sales team via bachem.com.
Should You Order Bachem Peptides?
Bachem is the right choice for pharmaceutical and biotech organizations that require GMP-certified peptides with full regulatory documentation and a proven track record for clinical and commercial programs. No other CDMO matches Bachem’s combination of 50-plus years of peptide-exclusive expertise, four globally compliant manufacturing sites, and a portfolio supporting over 20 FDA-approved peptide drugs. The company’s position as supplier of approximately two-thirds of globally approved peptide APIs is the clearest measure of market confidence in its capabilities.
Bachem is not the right choice for individual researchers, academic labs operating on limited budgets, or buyers who need rapid turnaround on non-GMP research peptides. Better-value alternatives exist for research-grade needs. The decision comes down to regulatory requirements: buyers who need GMP compliance and regulatory support should order from Bachem, while those who don’t should evaluate more cost-competitive options first.